Turmeric acts as cell "disciplinarian" in body

16 March 2009

Revered in India as "holy powder," the marigold-colored spice known as turmeric has been used for centuries to treat wounds, infections and  other health problems. Yet, little has been known about exactly how  curcumin works.

Research published in the Journal of the American Chemical Society  claims that curcumin, a substance in turmeric, acts as a  "disciplinarian," inserting itself into cell membranes and making them  more orderly, a move that improves cells' resistance to infection and  malignancy.

Scientists have speculated that curcumin does its health-promoting work  by interacting directly with membrane proteins, but the new findings  challenge that notion. Instead, the researchers found that curcumin  regulates the action of proteins indirectly, by changing the physical  properties of the membrane.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight